Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Anastasilakis, Athanasios D.
157  Ergebnisse:
Personensuche X
?
1

Osteokines in Nonalcoholic Fatty Liver Disease:

Vachliotis, Ilias D. ; Anastasilakis, Athanasios D. ; Rafailidis, Vasileios.
Current Obesity Reports.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

The comparative effect of teriparatide and denosumab on act..:

Anastasilakis, Athanasios D ; Polyzos, Stergios A ; Makras, Polyzois..
Journal of Bone and Mineral Research.  39 (2024)  9 - p. 1306-1314 , 2024
Link: https://doi.org/10.1093/..
 
?
3

Nocebo-associated treatment discontinuation with subcutaneo..:

Yavropoulou, Maria P. ; Kasdagli, Maria-Iosifina ; Makras, Polyzois...
Maturitas.  179 (2024)  - p. 107874 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Romosozumab versus parathyroid hormone receptor agonists: w..:

Anastasilakis, Athanasios D ; Yavropoulou, Maria P ; Palermo, Andrea...
European Journal of Endocrinology.  191 (2024)  1 - p. R9-R21 , 2024
Link: https://doi.org/10.1093/..
 
?
5

Ostéoporose résultant de l'administration de glucocorticoïd..:

Anastasilakis, Athanasios D. ; Naciu, Anda Mihaela ; Yavropoulou, Maria P..
Revue du Rhumatisme.  91 (2024)  4 - p. 469-483 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Τhe story of sclerostin inhibition: the past, the present, ..:

Anastasilakis, Athanasios D. ; Tsourdi, Elena
Hormones.  , 2024
Link: https://doi.org/10.1007/..
 
?
7

Wnt/beta-catenin signaling inhibitors and nonalcoholic fatt..:

Polyzos, Stergios A ; Kountouras, Jannis ; Anastasilakis, Athanasios D.
Hepatobiliary & Pancreatic Diseases International.  22 (2023)  4 - p. 437-438 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Transient osteoporosis of the hip following discontinuation..:

Makras, Polyzois ; Yavropoulou, Maria P. ; Anastasilakis, Athanasios D....
Osteoporosis International.  35 (2023)  4 - p. 741-743 , 2023
Link: https://doi.org/10.1007/..
 
?
9

Similarities and Differences in the Management of Patients ..:

Anastasilakis, Athanasios D. ; Makras, Polyzois ; Paccou, Julien...
Journal of Clinical Medicine.  12 (2023)  18 - p. 5874 , 2023
Link: https://doi.org/10.3390/..
 
?
10

Efficacy of denosumab monotherapy among adults with Langerh..:

Makras, Polyzois ; Yavropoulou, Maria P. ; Chatziioannou, Sofia N....
American Journal of Hematology.  98 (2023)  7 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
11

Lipid Profile after Pharmacologic Discontinuation and Resto..:

Anastasilakis, Athanasios D. ; Polyzos, Stergios A. ; Vorkas, Panagiotis A....
Journal of Clinical Medicine.  12 (2023)  16 - p. 5430 , 2023
Link: https://doi.org/10.3390/..
 
?
12

The relationship between length of denosumab treatment for ..:

Makras, Polyzois ; Yavropoulou, Maria P. ; Polyzos, Stergios A....
Osteoporosis International.  35 (2023)  2 - p. 365-370 , 2023
Link: https://doi.org/10.1007/..
 
?
13

Association of activins, follistatins and inhibins with inc..:

Anastasilakis, Athanasios D. ; Polyzos, Stergios A. ; Savvidis, Matthaios...
Endocrine.  81 (2023)  3 - p. 573-578 , 2023
Link: https://doi.org/10.1007/..
 
?
14

Risk and management of osteoporosis due to inhaled, epidura..:

Anastasilakis, Athanasios D. ; Naciu, Anda Mihaela ; Yavropoulou, Maria P..
Joint Bone Spine.  90 (2023)  6 - p. 105604 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Activins, follistatins and inhibins in postmenopausal osteo..:

Anastasilakis, Athanasios D. ; Polyzos, Stergios A. ; Rodopaios, Nikolaos E....
Metabolism.  141 (2023)  - p. 155397 , 2023
Link: https://doi.org/10.1016/..
 
1-15